Open Access
Heparinin İndüklediği Trombositopeni: Olgu sunumu
Alperen Kısa1*
1Hitit University, Çorum, Turkey
* Corresponding author: alperenkisa@hotmail.com.tr

Presented at the 4th International Symposium on Innovative Approaches in Health and Sports Sciences (ISAS WINTER-2019 (HSS)), Samsun, Turkey, Nov 22, 2019

SETSCI Conference Proceedings, 2019, 12, Page (s): 115-117 , https://doi.org/10.36287/setsci.4.9.076

Published Date: 23 December 2019    | 719     14

Abstract

Heparinin indüklediği trombositopeni (HİT), heparin kullanımı sonrası immünolojik mekanizmalar yoluyla gelişen, arteriyel ve venöz tromboembolizm ile karakterize katastrofik  nadir görülen bir komplikasyondur. heparin kullanımını takiben genellikle 5-14. günlerde gelişir. HİT geliştiğinde heparin tedavisi kesilmeli ve direkt trombin inhibitörleri başlanmalıdır.Bu yazıda HİT’ye bağlı tromboembolik komplikasyonlar gelişen bir olgu sunarak nadir görülen bu komplikasyona farkındalık oluşturmayı amaçladık.

Keywords - heparin, trombositopeni,tromboemboli

References

1. Franchini M. Heparin-induced thrombocytopenia: an update. Thrombosis Journal 2005; 3: 14.
2. Warkentin TE, Grienacher A. Heparin-induced thrombocytopenia: recognition, treatment, and prevention. Chest 2004; 126: 311-37.
3. Pappalardo F, Crescenzi G, Franco A, Zangrillo A. Early heparin-induced thrombocytopaenia (HIT) after cardiac surgery. Eur J Anaesthesiol 2006;23:806-8.
4. Warkentin TE, Greinacher A, Koster A, Lincoff AM; American College of Chest Physicians Chest. Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008;133(6 Suppl):340S-380S
5. Kuo KH, Kovacs MJ. Fondaparinux: A potential new therapy for HIT. Hematology, 10(4): 271-5, 2005. 8. Francis CW. Direct thrombin inhibitors for treatment of heparin induced thrombocytopenia, deep vein thrombosis and atrial fibrillation. Curr Pharm Des 11(30): 3931-41, 2005.
6. Francis CW. Direct thrombin inhibitors for treatment of heparin induced thrombocytopenia, deep vein thrombosis and atrial fibrillation. Curr Pharm Des 11(30): 3931-41, 2005
7. Otis SA and Zehnder JL. Heparin-induced thrombocytopenia: Current status and diagnostic challenges. Am J Hematol 2010; 85:700–706.
8. Refaai MA, Van Cott EM, Laposata M. The timing of a positive test result for heparin- induced thrombocytopenia relative to the platelet count and anticoagulant therapy in 43 consecutive cases. Am J Clin Pathol 119: 497-504, 2003.

SETSCI 2024
info@set-science.com
Copyright © 2024 SETECH
Tokat Technology Development Zone Gaziosmanpaşa University Taşlıçiftlik Campus, 60240 TOKAT-TÜRKİYE